Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Cue Biopharma is a biotechnology business based in the US. Cue Biopharma stocks (CUE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $11.01 – a decrease of 8.37% over the previous week. Cue Biopharma employs 51 staff and has a trailing 12-month revenue of around $432,227.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Latest market close | $3.72 |
|---|---|
| 52-week range | $2.18 - $5.12 |
| 50-day moving average | $3.89 |
| 200-day moving average | $3.27 |
| Wall St. target price | $10.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.32 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $3.72 from 2023-06-07
| 1 week (2023-06-01) | -8.37% |
|---|---|
| 1 month (2023-05-08) | -24.24% |
| 3 months (2023-03-08) | 33.33% |
| 6 months (2022-12-08) | 14.81% |
| 1 year (2022-06-08) | -1.59% |
|---|---|
| 2 years (2021-06-07) | -72.71% |
| 3 years (2020-06-08) | 25.5 |
| 5 years (2018-06-08) | 14.22 |
| Revenue TTM | $432,227 |
|---|---|
| Gross profit TTM | $1.2 million |
| Return on assets TTM | -38.17% |
| Return on equity TTM | -86.67% |
| Profit margin | 0% |
| Book value | $1.27 |
| Market capitalisation | $177.5 million |
TTM: trailing 12 months
We're not expecting Cue Biopharma to pay a dividend over the next 12 months.
Over the last 12 months, Cue Biopharma's shares have ranged in value from as little as $2.18 up to $5.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cue Biopharma's is 2.0106. This would suggest that Cue Biopharma's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company, develops injectable biologics to selectively engage and modulate tumor-specific T cells within the body to treat a range of cancers, chronic infectious diseases, and autoimmune diseases. Its lead drug product candidate is CUE-101, a fusion protein biologic designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate with Immuno-STAT targeting the KRAS G12V mutation, as well as cancer antigen MAGE-A4; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; and LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
